Kyowa Kirin markets its products globally. Bonds & Ratings. Close.
Management Plan. Investors. Share Data.
Investors - Top | Investors | Kyowa Kirin Co., Ltd. Business Risk Factors.
Search . Financial Data Financial Data Key Financial Data. Introduction of Kyowa Kirin Co., Ltd. Investor Relations.
Directors & Officers.
CSV Materiality and SDGs.
Management Plan . Shareholders' meeting. Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system diseases.
It operates through the Pharmaceuticals and Bio-Chemicals segments. Stock Chart.
Investors. Stock analysis for Kyowa Kirin Co Ltd (4151:Tokyo) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Articles of Incorporation.
Kyowa Hakko Kirin Co. Ltd. Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. Cash Flow Data. Dividends. Key Financial Ratios. Corporate Governance. Search. Stock Chart Annual Report. The Company produces anti-allergic agent, treating hypertension and angina pectoris agent, ulcerative colitis agent, anti-epileptic agent, and more. CSV Materiality and SDGs. Governance Governance Top message. Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Business Risk Factors. Main Menu open.
Annual Report. Corporate Website. Directors & Officers. GRI Standard Index.
ESG Data. ESG Data. Governance Governance Top message.
Corporate Governance. Find the latest KYOWA KIRIN CO LTD (4151.T) stock quote, history, news and other vital information to help you with your stock trading and investing. GRI Standard Index. Financial Tear Sheet.